EPISODE · Sep 8, 2022 · 33 MIN
225: Illumina's $8 billion limbo, a new treatment for ALS, & Emirati biotech funding
from The Readout Loud · host STAT
Our colleague Matthew Herper joins us to discuss how Illumina, the biggest company in genomic sequencing, got into an $8 billion predicament. We also discuss a dramatic development for a new ALS treatment, the latest in cancer research, and a well-funded new player in biotech venture capital.
Embed this episode
NOW PLAYING
225: Illumina's $8 billion limbo, a new treatment for ALS, & Emirati biotech funding
0:00
33:19
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Readout Loud?
This episode is 33 minutes long.
When was this The Readout Loud episode published?
This episode was published on September 8, 2022.
Can I download this The Readout Loud episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!